Form 4: Chemomab Therapeutics Director Sells Shares
Insider Transaction (Form 4)
Neil Harris Cohen, a Director of Chemomab Therapeutics Ltd., sold 2,304 shares of common stock on August 27, 2026.
Summary
- Open-market sale: disposed of 1,304 American Depositary Shares at $2.85 ($3,716) on August 27, 2026; holds 34,000 after (Direct).
- Open-market sale: disposed of 1,000 American Depositary Shares at $2.80 ($2,800) on August 28, 2026; holds 33,000 after (Direct).
- Grant/award: acquired 172 Stock option (right to buy American Depositary Shares) on July 16, 2020; holds 172 after (Direct).
- Grant/award: acquired 2,971 Stock option (right to buy American Depositary Shares) on April 19, 2021; holds 3,143 after (Direct).
- Grant/award: acquired 1,705 Stock option (right to buy American Depositary Shares) on March 7, 2022; holds 4,848 after (Direct).
- Grant/award: acquired 1,714 Stock option (right to buy American Depositary Shares) on March 21, 2023; holds 6,562 after (Direct).
- Grant/award: acquired 2,520 Stock option (right to buy American Depositary Shares) on March 18, 2024; holds 9,082 after (Direct).
- Grant/award: acquired 3,821 Stock option (right to buy American Depositary Shares) on March 16, 2025; holds 12,903 after (Direct).
- Grant/award: acquired 5,172 Stock option (right to buy American Depositary Shares) on March 16, 2026; holds 18,075 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $6,516 of stock on the open market.
Insider Transactions
Neil Harris Cohen — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Open-market sale | American Depositary Shares | 1,304 | $3 | $3.7K | 34,000 |
| 2026-08-28 | Open-market sale | American Depositary Shares | 1,000 | $3 | $2.8K | 33,000 |
| 2020-07-16 | Grant/award | Stock option (right to buy American Depositary Shares) | 172 | — | — | 172 |
| 2021-04-19 | Grant/award | Stock option (right to buy American Depositary Shares) | 2,971 | — | — | 3,143 |
| 2022-03-07 | Grant/award | Stock option (right to buy American Depositary Shares) | 1,705 | — | — | 4,848 |
| 2023-03-21 | Grant/award | Stock option (right to buy American Depositary Shares) | 1,714 | — | — | 6,562 |
| 2024-03-18 | Grant/award | Stock option (right to buy American Depositary Shares) | 2,520 | — | — | 9,082 |
| 2025-03-16 | Grant/award | Stock option (right to buy American Depositary Shares) | 3,821 | — | — | 12,903 |
| 2026-03-16 | Grant/award | Stock option (right to buy American Depositary Shares) | 5,172 | — | — | 18,075 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Open-market sale (1,304 shares) |
| 2026-08-28 | Open-market sale (1,000 shares) |
| 2020-07-16 | Grant/award (172 shares) |
| 2021-04-19 | Grant/award (2,971 shares) |
| 2022-03-07 | Grant/award (1,705 shares) |
| 2023-03-21 | Grant/award (1,714 shares) |
| 2024-03-18 | Grant/award (2,520 shares) |
| 2025-03-16 | Grant/award (3,821 shares) |
| 2026-03-16 | Grant/award (5,172 shares) |
Keywords
insider transaction, Form 4, CMMB, Chemomab Therapeutics Ltd., bearish, Neil Harris Cohen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.